Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• Senseonics Holdings has a consensus analyst rating of “Moderate Buy” from six covering firms, with an average 12-month price target of $17.00.
• The company recently reported Q1 earnings of -$0.71 per share, missing estimates, on $11.71 million in revenue; analysts expect it to post -2.38 EPS for the current year.
• Insiders have been buying shares, including the CEO and a director, while hedge funds such as Bank of America and Masters Capital Management also increased their holdings.

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) have received a consensus rating of "Moderate Buy" from the six research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $17.00.

Several equities analysts recently commented on the stock. Weiss Ratings initiated coverage on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday, February 17th. They set a "sell (d-)" rating on the stock. HC Wainwright cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating for the company in a research report on Tuesday, May 12th. Finally, Stifel Nicolaus reduced their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Monday, May 11th.

Senseonics Holdings, Inc. Common Stock Price Performance

NASDAQ:SENS opened at $6.72 on Friday. The company has a market cap of $280.90 million, a P/E ratio of -3.36 and a beta of 1.05. The stock has a 50 day moving average price of $6.39. The company has a quick ratio of 3.19, a current ratio of 3.51 and a debt-to-equity ratio of 1.05. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $12.58.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing analysts' consensus estimates of ($0.65) by ($0.06). The business had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. As a group, sell-side analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.38 EPS for the current year.

Insider Activity

In related news, Director Douglas A. Roeder purchased 22,686 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average cost of $5.56 per share, for a total transaction of $126,134.16. Following the transaction, the director directly owned 144,635 shares in the company, valued at $804,170.60. The trade was a 18.60% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Timothy T. Goodnow purchased 17,225 shares of the firm's stock in a transaction on Friday, March 13th. The stock was bought at an average cost of $5.79 per share, for a total transaction of $99,732.75. Following the completion of the purchase, the chief executive officer directly owned 651,243 shares in the company, valued at approximately $3,770,696.97. This trade represents a 2.72% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 57,411 shares of company stock valued at $326,142 over the last 90 days. 4.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in SENS. Bank of America Corp DE raised its holdings in Senseonics Holdings, Inc. Common Stock by 126.8% during the 1st quarter. Bank of America Corp DE now owns 56,964 shares of the company's stock valued at $379,000 after buying an additional 31,849 shares during the last quarter. Masters Capital Management LLC grew its holdings in Senseonics Holdings, Inc. Common Stock by 100.0% in the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company's stock worth $3,330,000 after acquiring an additional 250,002 shares during the last quarter. Cetera Investment Advisers purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $85,000. Kestra Advisory Services LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $68,000. Finally, Aristides Capital LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at about $139,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.